Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

http://www.wikidata.org/entity/Q51020301

about

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Imago Mundi, Imago AD, Imago ADNI PET amyloid-beta imaging in preclinical Alzheimer's disease Neuroimaging of dementia in 2013: what radiologists need to know.Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Brain imaging of neurovascular dysfunction in Alzheimer's disease.Association of gray matter atrophy with age, β-amyloid, and cognition in aging APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.Molecular imaging of Alzheimer disease pathology Emerging biomarkers in cognition.Cerebrovascular disease, β-amyloid, and cognition in aging.Neuroimaging predictors of brain amyloidosis in mild cognitive impairment.Indicators of amyloid burden in a population-based study of cognitively normal elderly.Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.Voxel-based Morphometry of Brain MRI in Normal Aging and Alzheimer's Disease.Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly.Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes.Fibrillar amyloid correlates of preclinical cognitive decline.Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.Is amyloid-β harmful to the brain? Insights from human imaging studies Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer's Disease Neuroimaging Initiative.The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.Vascular risk and FDDNP-PET influence cognitive performance.Cerebral amyloid PET imaging in Alzheimer's disease.Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden.Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.The prognostic value of amyloid imaging.Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.

P2860

Q24594531-A6F3A8D7-C2C7-45D2-B373-98910D1B397B Q24595802-043EA267-05DE-491A-86E4-25A8E041DF66 Q28650395-7200C3BA-1F20-4F52-8399-00F84FC9FA6A Q30040695-1791C28C-017C-49AA-AE78-37B1C553EEFE Q30654332-85CB8A6E-6E3F-4F8B-AEF5-4893A62689A0 Q30666527-BCFBC9AE-D436-41CA-A9E7-2F15638CAE71 Q30971403-C1A465AF-720F-4B97-BE1B-269BC03E6552 Q31066988-310598AC-1452-45D5-8F17-D10A6ED3B87A Q33582714-07AF828A-4A10-425C-A5C4-4F2ED56526E2 Q33671934-B02AB919-59E1-48AE-9278-DCEE91216E45 Q34149444-EF256879-95AC-4766-AE6B-560B69F3D5DD Q34651135-B013E252-7C4F-43D5-ACB0-C1B1959A4A6E Q35008258-8F675A4C-F9B3-4700-B8C4-B71D901EDFE1 Q35742820-48187B34-FC3D-433B-8C92-1BD1ED361AF5 Q36155517-62E1F50E-6F99-427E-A6D0-3C95F2E0E3C7 Q36330933-AA9A585C-3AB2-4FE8-AA2D-CF580E7F7FE8 Q36456068-D6946503-D554-4988-8764-143D9B81E4EB Q36457001-D6204E3C-4000-4A90-97B9-DC010FD9815E Q36494813-16762DF9-03A3-490D-8DC6-54B0CCC9FB11 Q36603644-798539A3-AD4E-4B6A-B482-300DD95DB3F2 Q36679481-779FA599-037A-4BD0-A083-4D0A6DC76594 Q36958266-2F8871A8-7834-4A19-9980-375F60E303C0 Q37018071-FC391496-30D8-4C83-A40A-61DDE3E56F0D Q37184248-2941549A-BA11-473F-BB65-D11A585CDB4E Q37184490-629041BB-88C3-4519-A5D5-8B4B84772C0F Q37188315-94509ACC-F631-4F42-8D78-4C638E85F39E Q37265898-C63A8039-316A-4E9A-8CFA-440275880FA3 Q37297360-EFA546F4-4486-4DE1-889A-9305B314BA59 Q37417513-9670DDA8-5210-4E33-AF9C-7EE056BFF170 Q37459083-2B3940A1-70EE-4F1D-B599-D4A64292953A Q37483328-FC93AD58-7D42-4136-BEA1-43B914703152 Q37650253-C1D1EECE-0EF2-4806-9ACA-AF35F563FE15 Q37971458-8F39516E-33F3-41A3-BD76-E2134B331D88 Q38001577-ED6C92D6-55CD-4075-887A-4053AE99EC31 Q38178373-7C33A40C-4DBD-400D-825F-BB7C19C65901 Q38664541-0C85A436-ABB7-4CB1-939E-F6D89A8E62F0 Q38704916-460638DD-1F34-42CB-8E09-C644CDBCE83A Q38920888-D46EE265-2F54-47DE-A00E-8AD6D8B36B07 Q39613391-312DDF0D-AEB3-4836-B38B-FC51D9C59F80 Q40335688-DE731C8F-6944-44C8-8543-39207234600D

P2860

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

http://www.wikidata.org/entity/Q51020301

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Independent contribution of te ...... phase of Alzheimer's disease.

@en

Independent contribution of te ...... phase of Alzheimer's disease.

@nl

type

label

Independent contribution of te ...... phase of Alzheimer's disease.

@en

Independent contribution of te ...... phase of Alzheimer's disease.

@nl

prefLabel

Independent contribution of te ...... phase of Alzheimer's disease.

@en

Independent contribution of te ...... phase of Alzheimer's disease.

@nl

P1433

Q51020301-A24F41A8-77BB-4D56-B8C1-AF33B8AB5021

P1476

Q51020301-2C8593C4-0A8F-45BF-A903-38FAAECBF9C6

P2093

Q51020301-1E7B12F3-5EB5-45E1-A097-6BDBAA7466FC

Q51020301-30A2DAD7-B32B-4634-B84D-3AA326BB06FB

Q51020301-7E1204B0-288A-41C3-AF79-40A5EA14CFCD

Q51020301-8F8EC49E-644B-42F6-B8ED-FB8B3F437E0A

Q51020301-BDB34911-CE3C-400D-9CF9-418BA10D7ECD

Q51020301-F21BF3AF-7844-4E20-8A44-1F86D784B600

P2860

Q51020301-170BD140-6702-4701-9387-683B13797F3C

Q51020301-17F44F67-303D-41BF-94B9-E0B2D2280973

Q51020301-19EEE030-CFAE-406B-BAD2-E20B908E8B9E

Q51020301-219DC624-3DF6-4EAD-A36E-ABF1833DC764

Q51020301-22279A7A-4B5D-4290-A50A-5E08E89B9E4B

Q51020301-2B1663B0-2DF2-4227-9DE2-748C2ECA5C9A

Q51020301-3943BB65-3926-4830-AA29-F601AE26B507

Q51020301-3DBFFE9D-DF52-4B46-B791-E391B28BB778

Q51020301-3FD96D12-A6D3-4D43-AF8F-4A222BB61866

Q51020301-42EEAB3B-4699-45A8-AE06-43D09CC83C1C

P304

Q51020301-15BC7535-0199-4A9C-ADE0-05B68BFAE1B0

P31

Q51020301-B424DF77-9257-4EB6-8F05-3FF94B77499D

P356

Q51020301-17050382-2CAC-4387-BDB9-13063C5FE29E

P407

Q51020301-FE97639D-DB98-4969-A5AD-15600585BB95

P433

Q51020301-332392EF-A770-405F-A840-92230FF981FE

P478

Q51020301-B86B61F6-3346-4C15-B667-77D8D1000B27

P50

Q51020301-014531E7-51BE-495D-8227-72765112BF3B

Q51020301-031AC06B-631C-4F68-8183-F3F1595FC71B

Q51020301-36282D48-43B7-480A-ABBD-FA09F6F6570A

Q51020301-680F6F83-A371-491A-A9F1-B9094E79B366

Q51020301-68D74C11-41F6-429C-8358-A7521C9A197C

Q51020301-7240661E-1CB7-4A76-A33C-1D2E2187988B

Q51020301-756D0A72-F8C3-43E1-8EFA-DED082137488

Q51020301-C24833CE-ED7B-4D57-BB73-6CE66DB41222

P577

Q51020301-BB14F5A4-3CCA-4077-812A-959F61FE3DFC

P698

Q51020301-89CBBE8D-E679-42AD-8136-03F6C4A4753A

P356

P1433

P1476

Independent contribution of te ...... phase of Alzheimer's disease.

@en

P2093

Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group

http://www.w3.org/2001/XMLSchema#string

Christopher C Rowe

http://www.w3.org/2001/XMLSchema#string

David Ames

http://www.w3.org/2001/XMLSchema#string

Gaël Chételat

http://www.w3.org/2001/XMLSchema#string

Graeme J O'Keefe

http://www.w3.org/2001/XMLSchema#string

Victor L Villemagne

http://www.w3.org/2001/XMLSchema#string

P2860

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Voxel-based morphometry--the methods

Education modifies the relation of AD pathology to level of cognitive function in older persons

Disruption of functional connectivity in clinically normal older adults harboring amyloid burden.

Amyloid imaging in mild cognitive impairment subtypes.

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.

Functional alterations in memory networks in early Alzheimer's disease.

Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia.

P304

798-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWQ383

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 3

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

Cassandra Szoeke

Gareth R. Jones

Pierrick Bourgeat

Olivier Salvado

Kathryn A Ellis

P577

2011-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21310725

http://www.w3.org/2001/XMLSchema#string